Neuro-Ophthalmology News

Neurotechnology company Synchron announced the first use of Apple Vision Pro with a patient implanted with its brain-computer interface, which allows users to make commands without using their hands or voice.

PHILADELPHIA — In this video, Michael Fisher, MD, discusses the results of a natural history study he presented at the International Symposium on Pediatric Neuro-Oncology.

SAN DIEGO – Spontaneous intracranial hypotension led to significant physical, mental and quality of life impact for a cohort of those with the condition, according to a speaker at the American Headache Society Annual Scientific Meeting.

Patients with idiopathic infantile nystagmus syndrome had better best-corrected visual acuity but scored lower on quality-of-life assessments compared with those whose condition was associated with ocular disease, according to research.

Use of polarization-sensitive OCT to identify scleral fiber patterns in highly myopic eyes may help develop targeted therapies for scleral abnormalities and mitigate damage to surrounding neural tissue, according to research.

DENVER — Daily treatment with a suspension of gold crystals was linked to improved outcomes at 96 weeks for those with stable relapsing multiple sclerosis, according to a speaker at the American Academy of Neurology annual meeting.

The FDA approved Ultomiris for the treatment of adults with anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder, according to a press release from Alexion.

Increased physical activity may be associated with slower rates of macular ganglion cell-inner plexiform layer thinning, according to a study published in Investigative Ophthalmology & Visual Science.

Presence of cytokine proteins in those with neuromyelitis optica spectrum disorder was linked to disease activity, which was lessened after treatment with inebilizumab, according to a presentation from ECTRIMS 2023.